Large Cap / Pharmaceuticals, Biotechnology & Life Sciences
BMY Commences Tender Offer to Purchase All Outstanding Shares of AMLN

Bristol-Myers Squibb Began Tender Offer to Acquire Amylin Pharmaceuticals, Inc.

July 10, 2012

On July 10, 2012, Bristol-Myers Squibb Company (NYSE: BMY) commenced a cash tender offer to purchase all outstanding shares of common stock of Amylin Pharmaceuticals, Inc.

To view the full article, please subscribe or login.

Your Financial Security is Serious Business...

so why should you trust The Turnaround Letter?

  • Ranked Among Top-2 for 15-Yr. Returns: Turnaround Letter's 12.1% vs. S&P's 2.5%
  • 28+ Years of Turnaround Investing Experience & Reliable Stock Market Advice
  • Diverse Monthly Stock Picks Personally Selected by George Putnam

Distressed Investing Blog

Distressed Investing Blog

Value Stock Case Study | FCH's 150+% Profit Margin

FCH is a prime example of the benefits of thorough analysis, a prudent investing strategy and the benefits of knowing when to sell and lock in profit. Those factors teamed up to give Turnaround Letter readers a solid 150+% gain with this stock—and a timely reminder to respect the old Wall Street adage: "Bulls make money; bears make money but pigs get slaughtered." Read More.

Free Stock Picks

stock picks

TL Spotlight

George Putnam has always followed the same straight-forward and highly-profitable investment philosophy. He published his first Turnaround Letter issue back in 1986, and readers have seen extraordinary long-term stock profit ever since.

 

In fact, 12 of 2014's 13 closed-out purchase recommendations saw gains--with five of those enjoying total returns greater than 100%. The Turnaround Letter's average return for 2014's stock picks is +82%:

 

2014 Closed Out Purchase Recommendations

Value Stock Picks

* Calculation includes dividends and price changes between purchase recommendation and current price.

 

Learn more.